Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Demartino

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
JAMA Pediatrics|March 22, 2021
A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: The Medicaid PerspectivePatrick DeMartino, Meredith B Haag, Alyssa R Hersh, et al.
The Milbank Quarterly|January 18, 2025
Innovative Insurance to Improve US Patient Access to Cell and Gene TherapyRena M Conti, Patrick Demartino, Jonathan Gruber, et al.
Transplantation and Cellular Therapy|August 14, 2023
Assessing Medicaid Coverage for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy: A Project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS InitiativeJeffery J Auletta, Nandita Khera, Patrick DeMartino, et al.
Blood Reviews|July 7, 2026
What population-based databases reveal about equity in access to hematopoietic cell transplant and cellular therapySanghee Hong, Manuel Ricardo Espinoza-Gutarra, Rahul Shah, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
JAMA Pediatrics|March 22, 2021
A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: The Medicaid PerspectivePatrick DeMartino, Meredith B Haag, Alyssa R Hersh, et al.
The Milbank Quarterly|January 18, 2025
Innovative Insurance to Improve US Patient Access to Cell and Gene TherapyRena M Conti, Patrick Demartino, Jonathan Gruber, et al.
Transplantation and Cellular Therapy|August 14, 2023
Assessing Medicaid Coverage for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy: A Project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS InitiativeJeffery J Auletta, Nandita Khera, Patrick DeMartino, et al.
Blood Reviews|July 7, 2026
What population-based databases reveal about equity in access to hematopoietic cell transplant and cellular therapySanghee Hong, Manuel Ricardo Espinoza-Gutarra, Rahul Shah, et al.
Pageof 1